This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

PSS World Medical Upgraded After October Slide

NEW YORK (AP) ¿ A Raymond James analyst upgraded shares of medical products distributor PSS World Medical Inc. on Tuesday, saying a recent sell-off makes the stock more attractive.

John Ransom raised his rating on the stock to "outperform" from "market perform," saying Wall Street's expectations for PSS World have become more realistic in recent weeks. He added that the company could surpass analyst estimates if its profit margins improve and the company takes advantage of its solid financial position.

The stock was up 33 cents, or 1.7 percent, at $19.68 in afternoon trading.

The Jacksonville, Fla., company's shares have fallen 15 percent after reaching their highest closing price of the year on Oct. 19. Ransom said traders who were looking to make a quick profit off of PSS World's sales of swine flu products have now sold their shares, and he said the stock should outperform the market again.

In late October, PSS World reported $23 million in produce sales from swine flu in the fiscal second quarter. It then raised its profit estimate for the year, mostly due to sales of swine flu related products. But that has not staved off a decline in the shares.

Ransom said PSS World could use its available cash and credit to make an acquisition or buy back stock, which could boost its results.
Copyright 2009 Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.10 -1.80%
FB $116.73 0.00%
GOOG $690.40 -0.09%
TSLA $238.99 -3.50%
YHOO $36.34 -0.68%


Chart of I:DJI
DOW 17,707.69 -123.07 -0.69%
S&P 500 2,053.11 -22.70 -1.09%
NASDAQ 4,750.9110 -54.38 -1.13%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs